Skip to main content
Biotest AG logo

Biotest AG — Investor Relations & Filings

Ticker · BIO3 ISIN · DE0005227201 LEI · 529900JVX7RPXBLYUD89 F Manufacturing
Open in API
Filings indexed 1,148 across all filing types
Latest filing 2018-11-14 Investor Presentation
Country DE Germany
Listing F BIO3

About Biotest AG

https://www.biotest.com/de/en/index.cfm

Biotest AG is a global company that develops, manufactures, and supplies plasma protein products and biotherapeutic drugs. Sourced from human blood plasma, its products are primarily used in the therapeutic areas of clinical immunology, haematology, and intensive care medicine. The portfolio includes immunoglobulins (e.g., Intratect), coagulation factors, and albumins designed to treat severe and chronic diseases such as immune deficiencies, haemophilia, and coagulation disorders. The company manages the entire value chain from clinical development to sales and is advancing a pipeline of new treatments, including next-generation immunoglobulins (BT595) and fibrinogen concentrates (BT524). Biotest also provides Human Serum Albumin for use as a multifunctional excipient in pharmaceutical and diagnostic applications.

Recent filings

Filing Released Lang Actions
Investor Presentation 2018
Investor Presentation Classification · 100% confidence The document is titled 'Analyst call - Nine months 2018' and contains detailed financial tables, segment performance (Sales, EBIT), income statement figures, cash flow analysis, and updates on strategic projects ('Biotest Next Level', clinical trials). This structure strongly indicates a comprehensive report detailing performance over a nine-month period, which aligns with the definition of an Interim/Quarterly Report (IR). Although it is presented in a format suitable for an analyst call, the content itself is the detailed financial reporting for the period, not just a brief release or a transcript of the call itself. Since it covers nine months (Q1-Q3), it is more specific than a general Earnings Release (ER) and fits the 'Interim / Quarterly Report' (IR) category.
2018-11-14 English
Investor Presentation 2018
Investor Presentation Classification · 100% confidence The document is titled 'Analyst call - Nine months 2018' and contains detailed financial tables, segment performance (Sales, EBIT), income statement figures, cash flow analysis, and updates on strategic projects ('Biotest Next Level', clinical trials). This structure strongly indicates a comprehensive report detailing performance over a nine-month period, which aligns with the definition of an Interim/Quarterly Report (IR). Although it is presented in a format suitable for an analyst call, the content itself is the detailed financial reporting for the period, not just a brief release or a transcript of the call itself. Since it covers nine months (Q1-Q3), it is more specific than a general Earnings Release (ER) and fits the 'Interim / Quarterly Report' (IR) category.
2018-11-14 German
Q3 statement / Q3 financial report 2018
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Statement' for the period 1 January to 30 September 2018. It contains detailed financial tables (Revenue, EBITDA, EBIT, etc.), a business performance review, and consolidated financial statements. It is a comprehensive report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-11-14 German
Report Publication Announcement 2018
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG". It explicitly states that it is announcing *when* various reports (Annual financial report, Financial report (half-year/Q2)) will be disclosed in the future (e.g., March 28, 2019, and August 14, 2019). This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports, rather than being the report itself. The document length (2420 chars) is also short, supporting the RPA classification based on the 'MENU VS MEAL' rule.
2018-11-12 English
Report Publication Announcement 2018
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of quarterly reports and quarterly/interim statements" and explicitly states the dates when future financial reports (Q1 and Q3 reports for 2019) will be disclosed. It is not the report itself, but an announcement about the timing of future report publications. According to Rule 2 (The 'MENU VS MEAL' RULE), a short document announcing the publication of reports falls under Report Publication Announcement (RPA).
2018-11-12 English
Hinweis auf Quartalsfinanzbericht vom 01.01.2019 bis zum 30.09.2019
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 1,000 characters) that informs stakeholders about the availability of a quarterly financial report. It provides a link to the report on the company website and specifies the publication date. According to the 'Menu vs Meal' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2018-11-12 German

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.